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ndosomes in yeast have been hypothesized to move
through the cytoplasm by the momentum gained
after actin polymerization has driven endosome
abscision from the plasma membrane. Alternatively, after
abscission, ongoing actin polymerization on endosomes
could power transport. Here, we tested these hypotheses
by showing that the Arp2/3 complex activation domain
(WCA) of Las17 (Wiskott-Aldrich syndrome protein
[WASp] homologue) fused to an endocytic cargo protein
(Ste2) rescued endosome motility in 
 
las17
 
 
 
WCA mutants,
and that capping actin ﬁlament barbed ends inhibited
E
 
endosome motility but not endocytic internalization. Mo-
tility therefore requires continual actin polymerization on
endosomes. We also explored how Las17 is regulated.
Endosome motility required the Las17-binding protein
Lsb6, a type II phosphatidylinositol 4-kinase. Catalytically
inactive Lsb6 interacted with Las17 and promoted endo-
some motility. Lsb6 therefore is a novel regulator of Las17
that mediates endosome motility independent of phos-
phatidylinositol 4-phosphate synthesis. Mammalian type
II phosphatidylinositol 4-kinases may regulate WASp
proteins and endosome motility.
 
Introduction
 
Endocytosis regulates signaling by cell surface receptors, in-
cluding hundreds of growth factor receptors and G protein–
coupled receptors (GPCRs; for review see Engqvist-Goldstein
and Drubin, 2003; Qualmann et al., 2000; Sorkin and Von
Zastrow, 2002; Gaborik and Hunyady, 2004). Endocytosis
can attenuate signaling when internalized receptors are trans-
ported to lysosomes and degraded. Conversely, endocytosis
can promote signaling, as indicated by the ability of internal-
ized GPCRs to activate MAP kinase cascades and/or recycle to
the plasma membrane for further rounds of agonist stimulation.
Internalized receptors use several mechanisms to move
within minutes from the plasma membrane to lysosomes. Motor
proteins such as myosin VI and myosin V can move endosomes
along actin filaments near the cell cortex (Schott et al., 1999;
Aschenbrenner et al., 2003; Hasson, 2003; Soldati, 2003), and
kinesin and dynein can move endosomes along microtubules
over longer distances (Aniento et al., 1993; Apodaca, 2001;
Bananis et al., 2003). Actin polymerization can also power en-
dosome movement (Taunton et al., 2000), similar to mecha-
nisms that transport intracellular pathogens (Loisel et al.,
1999), macropinosomes (Merrifield et al., 2001; Seastone et
al., 2001), and the insulin-responsive glucose transporter Glut4
(Kanzaki et al., 2001). These actin polymerization-dependent
transport mechanisms are thought to use the Arp2/3 complex to
nucleate ongoing and continuous assembly of branched actin
filament networks on organelle membranes (reviewed in Schafer,
2002). The WASp/SCAR/WAVE family of proteins are potent
activators of the Arp2/3 complex (Pollard and Borisy, 2003),
and have been implicated in promoting motility of endosomes
and other organelles (Taunton et al., 2000; Southwick et al.,
2003). Indeed, we have shown that Las17, the sole WASp
homologue of yeast, is required for motility of endosomes
containing the GPCR Ste2 (Chang et al., 2003).
Actin dynamics may power organelle motility by other
mechanisms as suggested by studies of endocytosis in yeast.
In one model, actin polymerization-driven internalization im-
parts momentum that carries endosomes through the cytoplasm
(Kaksonen et al., 2003). In support of this model, the WASp
homologue Las17 and the actin binding protein Abp1 are de-
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tected on cortical actin patches as they internalize but are de-
pleted from endosomes moving away from the cortex (Kaksonen
et al., 2003). However, the distance or speed with which endo-
somes could travel through the viscous cytoplasm by such a
mechanism is unclear. In a second mechanism, a subpopulation
of endosomes have been shown to bind cytoplasmic F-actin ca-
bles that treadmill, transporting endosomes to the lysosome-
like vacuole (Huckaba et al., 2004).
Mechanisms regulating actin polymerization-dependent
endosome and organelle motility have emerged from studies of
WASp/SCAR/WAVE proteins. WASp proteins are autoinhib-
ited and form complexes with accessory proteins including
WIP and TOCA-1 (Moreau et al., 2000; Ho et al., 2004). Phos-
phoinositides such as phosphatidylinositol 4,5-bisphosphate
(PI4,5P2; PIP2) in concert with GTP-loaded Cdc42 or Rac1
can bind and activate WASp in vitro (Kanzaki et al., 2001;
Benesch et al., 2002; Sokac et al., 2003) by exposing the
WASp COOH-terminal Arp2/3 complex activating region
(WCA) domain (reviewed in Higgs and Pollard, 2001). Fur-
thermore, overexpression of phosphatidylinositol 4-phosphate
(PI4P)5-kinase induces N-WASP–dependent motility of endo-
somes and other organelles (Rozelle et al., 2000; Taunton et al.,
2000). Regulation of SCAR/WAVE proteins is less well under-
stood. SCAR/WAVE proteins are constitutively active, but can
be stabilized in inactive complexes with accessory proteins
(Nap1, Abi2, HSPC300; Eden et al., 2002; Innocenti et al.,
2004; Steffen et al., 2004).
Here we have addressed whether endosomes in yeast
move by the momentum gained upon actin polymerization-
driven abscission from the plasma membrane or by continuously
polymerizing actin on endosome membranes after abscission.
We also address how the yeast WASp homologue Las17 is reg-
ulated to drive endosome motility. Our findings indicate that
endosome motility requires continuous actin polymerization
on endosomes, and that Lsb6, a type II phosphatidylinositol
4-kinase (PI 4-kinase) of previously unknown function, regu-
lates endosome motility by interacting with Las17 rather than
by catalyzing PI4P synthesis.
 
Results
 
Ongoing actin polymerization powers 
endosome motility
 
To address whether endosomes move by continuously poly-
merizing actin after abscission from the plasma membrane, we
appended the domain of the WASp homologue (Las17) that ac-
tivates the Arp2/3 complex (WCA domain; COOH-terminal 90
amino acids; Winter et al., 1999; Higgs and Pollard, 2001) to
the COOH terminus of the endocytic cargo Ste2 (Ste2-WCA).
As a control, the WCA domain also was fused to a highly ex-
 
Table I. 
 
Endosome speeds
Strain
 
n
 
  Average speed Significant defect?
 
a
 
WT
 
 
 
 vector 23
 
 
 
36 0.19 
 
 
 
 0.02 —
lsb6
 
  
 
 vector 23
 
 
 
50 0.09 
 
 
 
 0.01 Yes
lsb6
 
  
 
 pLSB6 23
 
 
 
48 0.20 
 
 
 
 0.01 No
WT
 
 
 
 Ste2-WCA 23
 
 
 
58 0.14 
 
 
 
 0.01 No
las17
 
 
 
WCA
 
 
 
 vector 23
 
 
 
72 0.09 
 
 
 
 0.01 Yes
 
 
 
 Ste2-WCA 23
 
 
 
67 0.18 
 
 
 
 0.01 No
 
 
 
 Hxt1-WCA 23
 
 
 
51 0.09 
 
 
 
 0.01 Yes
lsb6
 
  
 
 Ste2-WCA 23
 
 
 
45 0.15 
 
 
 
 0.01 No
 
 
 
 Hxt1-WCA 23
 
 
 
60 0.10 
 
 
 
 0.01 Yes
WT
 
 
 
 Gal Cap1/2 Raffinose 57 0.14 
 
 
 
 0.01 —
 
 
 
 Gal Cap1/2 Galactose 57 0.08 
 
 
 
 0.02 Yes
lsb6
 
  
 
 Lsb6 K192M 23
 
 
 
28 0.16 
 
 
 
 0.01 No
 
 
 
 Lsb6 D387A 23
 
 
 
25 0.15 
 
 
 
 0.01 No
 
 
 
 Lsb6 N392A 23
 
 
 
28 0.17 
 
 
 
 0.01 No
 
 
 
 Lsb6 D413A 23
 
 
 
25 0.18 
 
 
 
 0.02 No
 
 
 
 Lsb6 K192M (CEN) 23
 
 
 
54 0.18 
 
 
 
 0.01 No
 
 
 
 Lsb6 4KD 23
 
 
 
35 0.19 
 
 
 
 0.01 No
lsb6
 
  
 
 Lsb6 
 
 
 
N-terminus 23
 
 
 
59 0.07 
 
 
 
 0.01 Yes
 
 
 
 Lsb6 
 
 
 
kinase subdomain 1 23
 
 
 
47 0.11 
 
 
 
 0.02 No
 
 
 
 Lsb6 
 
 
 
linker 23
 
 
 
47 0.11 
 
 
 
 0.01 No
 
 
 
 Lsb6 
 
 
 
kinase subdomain 2 23
 
 
 
47 0.14 
 
 
 
 0.01 No
 
 
 
 Lsb6 
 
 
 
C-terminus 23
 
 
 
59 0.13 
 
 
 
 0.01 No
 
 
 
 Lsb6 N-terminus 23
 
 
 
52 0.12 
 
 
 
 0.01 No
 
 
 
 Lsb6 kinase subdomain 1 23
 
 
 
49 0.10 
 
 
 
 0.01 Yes
 
 
 
 Lsb6 N-terminus 
 
 
 
 kinase subdomain 1 23
 
 
 
48 0.15 
 
 
 
 0.01 No
 
 
 
 Lsb6 kinase subdomain 1 
 
 
 
 linker 23
 
 
 
52 0.06 
 
 
 
 0.01 Yes
 
 
 
 Lsb6 kinase subdomain 2 23
 
 
 
43 0.08 
 
 
 
 0.01 Yes
 
 
 
 Lsb6 C-terminus 23
 
 
 
46 0.08 
 
 
 
 0.01 Yes
 
a
 
Average endosome speed, SEM, and P values were calculated by imaging 25–72 endosomes taken from three independent transformants in each of two to
four experiments.
P 
 
  
 
0.005 to paired wild-type control. 
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pressed glucose transporter (Hxt1-WCA) that localizes to the
plasma membrane but does not undergo endocytosis when glu-
cose is abundant (Schmelzle et al., 2004). We expressed Ste2-
WCA or Hxt1-WCA in a mutant defective in endosome motility
(
 
las17
 
 
 
WCA, in which the chromosomal sequence encoding
the Las17 WCA domain was deleted; Chang et al., 2003). Ex-
pression of Ste2-WCA or Hxt1-WCA augmented the appear-
ance of cortical F-actin structures at the expense of cytoplasmic
F-actin cables (Fig. S1 A available at http://www.jcb.org/cgi/
content/full/jcb.200501086/DC1), indicating that both fusions
stimulated actin polymerization at the plasma membrane.
To determine whether expression of Ste2-WCA or Hxt1-
WCA could rescue the endosome motility defect of 
 
las17
 
 
 
WCA
mutants, we introduced Ste2-GFP into these cells as an endo-
some marker (Stefan and Blumer, 1999) and analyzed endosome
movement in these transformants by making single focal plane
time-lapse movies. Endosome (
 
n
 
 
 
  
 
25–50) motility in each mu-
tant was measured by calculating average speed, distribution of
speeds, and by tracing paths of endosome motion over a 5–10-s
period. Using these methods we showed previously that endo-
somes labeled with Ste2-GFP in wild-type cells move with an
average speed of 
 
 
 
0.2 
 
 
 
m/s, travel along paths of various length
with marked changes in direction, and often leave the plane of
focus within a few seconds (Chang et al., 2003).
Ste2-WCA and Hxt1-WCA fusions had strikingly differ-
ent effects on the motility of endosomes labeled with Ste2-GFP
in a 
 
las17
 
 
 
WCA mutant (Table I). Because Ste2 efficiently
and constitutively forms homooligomers (Overton and Blumer,
2000), Ste2-WCA and Ste2-GFP will traffic together during
endocytosis. Using this approach, we found that expression of
Ste2-WCA fully rescued the endosome motility defect of a
 
las17
 
 
 
WCA mutant. Rescued cells displayed an average endo-
some speed of 0.18 
 
 
 
 0.01 
 
 
 
m/s relative to that of 0.08 
 
 
 
 0.01
 
 
 
m/s in empty vector control cells. As occurs in wild-type
cells, endosomes in rescued cells traveled along paths that were
long and changed direction, often leaving the plane of focus af-
ter a few seconds. In contrast, although Hxt1-WCA was highly
overexpressed on the plasma membrane in a pattern indistin-
guishable from Ste2 (Fig. S1 B available at http://www.jcb.org/
cgi/content/full/jcb.200501086/DC1), it failed to rescue the
endosome motility defect of 
 
las17
 
 
 
WCA mutants (Table I).
These results are illustrated in Video S1 (endosome motility in
a 
 
las17
 
 
 
WCA cell   vector), Video S2 (endosome motility in
a las17 WCA cell   Ste2-WCA), and Video S3 (endosome
motility in a las17 WCA cell   Hxt1-WCA; videos available
at http://www.jcb.org/cgi/content/full/jcb.200501086/DC1).
To obtain and analyze endosome motility more quantita-
tively, we used an automated particle tracking program devel-
oped to study actin patch motility in yeast (Carlsson et al.,
2002). The resultant data were plotted as the mean squared dis-
placement (MSD) of endosomes (n   50–150) over time. This
analysis indicated that endosomes labeled with Ste2-GFP were
poorly motile in las17 WCA cells carrying an empty vector or
a plasmid overexpressing Hxt1-WCA, as indicated by rela-
tively flat curves in MSD plots (Fig. 1). In contrast, endosomes
in the las17 WCA mutant expressing Ste2-WCA exhibited
wild-type motility, as indicated by significantly greater dis-
placement over time. Because under these conditions Ste2 is
recruited to endosomes whereas Hxt1 is not, these results sug-
gested that actin polymerization on endosomes rather than the
plasma membrane promotes motility.
To test this hypothesis further, we examined whether en-
dosome motility in wild-type cells requires polymerization from
free barbed ends of actin filaments, as expected for Arp2/3 com-
plex–driven polymerization. Accordingly, we overexpressed the
barbed-end capping protein (Cap1   Cap2) from an inducible
promoter in wild-type cells (Fig. S1 C). Formation of cortical ac-
tin patches implicated in endocytic internalization is known to
be preserved upon overexpression of capping protein (Amatruda
et al., 1992; Kaksonen et al., 2000; Engqvist-Goldstein and
Drubin, 2003). Actin patch motility was strongly inhibited by
capping protein overexpression (unpublished data). Strikingly,
overexpression of capping protein strongly inhibited endosome
motility compared with uninduced control cells (average speed
0.08   0.02  m/s for induced versus 0.14   0.02  m/s for unin-
duced cells; Table I; Video S4 [endosome motility in a WT cell];
Video S5 [endosome motility in a WT cell   overexpressed
capping protein]; videos available at http://www.jcb.org/cgi/
content/full/jcb.200501086/DC1). Because endosomes labeled
with Ste2-GFP were produced when capping protein was over-
expressed, endocytic internalization was not blocked. These
results coupled with those using Ste2-WCA fusions therefore
provided independent lines of evidence indicating that Ste2-
labeled endosomes move via continuous Arp2/3 complex–
mediated polymerization of actin filaments on endosomes.
The type II PI 4-kinase Lsb6 is required 
for endosome motility
Little is known about the mechanisms that regulate Las17.
Purified Las17 appears to be constitutively active, yet it can
be inhibited in vitro by the SH3-domain proteins Bbc1 and
Sla1 (Rodal et al., 2003). It remains unknown whether Las17 in
vivo is constitutively active or regulated by stimulatory or
inhibitory proteins or ligands.
Figure 1. Appending the WCA domain of Las17 to the endocytic cargo
Ste2 rescues endosome motility in las17 WCA cells. Automated particle
tracking was used to analyze endosome position over time. Ste2-GFP was
used as an endosome marker in this and subsequent figures. The mean
square displacement of endosomes (n   50–100) over time was calcu-
lated for the indicated wild-type and mutant cells.JCB • VOLUME 171 • NUMBER 1 • 2005 136
To identify proteins that may activate or recruit Las17 and
thereby promote motility of Ste2-containing endosomes, we ana-
lyzed mutants lacking proteins that were identified previously in
a two-hybrid screen as Las17-binding proteins (Lsb; Madania et
al., 1999). These proteins include Lsb1 and 2 (SH3 domain–con-
taining proteins similar to Grb2 or Grap2), Lsb3 and Lsb4 (SH3
domain–containing proteins similar to intersectin 1), Lsb5 (VRS
domain–containing protein like HRS), and Lsb6 (the single type
II PI 4-kinase homologue in yeast). Endosome motility was as-
sayed as described above in null mutants lacking each of these
Las17-interacting proteins, and in double mutants lacking pairs
of closely related proteins (Lsb1 and Lsb2, or Lsb3 and Lsb4).
Of the six single mutants and two double mutants analyzed,
lsb6  mutants displayed significant impairment of endosome
motility relative to wild-type cells. Endosomes in lsb6  and
wild-type cells moved with average speeds of 0.09   0.01  m/s
and 0.19   0.02  m/s, respectively (Table I). The average speed
of endosome motility in lsb6  mutants was similar to that ob-
served in cells expressing Las17 lacking its COOH-terminal
WCA domain (las17 WCA, 0.09   0.01  m/s) or in wild-type
cells treated with the actin-depolymerizing drug latrunculin A
(0.08   0.04  m/s; Chang et al., 2003). In lsb6  mutants, the
distribution of endosome speeds was shifted to lower values (Fig.
2 C), and endosomes moved along abnormally short paths that
remained within the plane of focus for many seconds (Fig. 2 B).
Impaired endosome motility in lsb6  mutants was rescued by ex-
pression of the wild-type LSB6 gene on a single-copy plasmid
(compare Video S6 [endosome motility in an lsb6  cell] with
Video S7 [endosome motility in an lsb6  cell   pLSB6]; videos
available at http://www.jcb.org/cgi/content/full/jcb.200501086/
DC1). These results were confirmed by performing automated
particle tracking and analyzing the data in MSD plots (Fig. S2 A).
These results indicated that Lsb6 is required for motility of Ste2-
containing endosomes. This is the first phenotype caused by the
absence of the sole type II PI 4-kinase of yeast.
Evidence that Lsb6 functions upstream 
of Las17
Because Lsb6 and Las17 interact and localize to the plasma
membrane (Madania et al., 1999; Eitzen et al., 2002; Han et al.,
2002), they may function in a common pathway in which Lsb6
acts upstream of Las17 to promote endosome motility. We
tested this hypothesis by determining whether expression of
Ste2-WCA could rescue the endosome motility defect of an
lsb6  mutant by bypassing the hypothesized impairment of
Las17 recruitment or activation caused by the absence of Lsb6.
We found that lsb6  cells expressing Ste2-WCA and Ste2-
GFP exhibited nearly wild-type endosome motility (average
speed was 0.15   0.01  m/s vs. 0.09   0.01  m/s for controls
lacking Ste2-WCA; Table I; Video S6 [endosome motility in a
lsb6  cell]). These results suggested that Las17 functions
downstream of Lsb6 in a pathway leading to activation of the
Arp2/3 complex, actin polymerization and endosome motility.
PI 4-kinase activity of Lsb6 is 
dispensable for endosome motility
Lsb6 is the only type II PI 4-kinase in yeast (Han et al., 2002;
Shelton et al., 2003). However, yeast also possesses two type
III PI 4-kinases, Stt4 and Pik1, each of which is essential for
cell growth (Audhya et al., 2000). Whereas Lsb6 synthesizes a
small fraction ( 5%) of the total PI4P pool, the remainder of
the PI4P pool is produced by Stt4 on the plasma membrane and
by Pik1 on Golgi membranes (Han et al., 2002). These plasma
membrane and Golgi PI4P pools have distinct functions be-
cause overexpression of Stt4 does not rescue the phenotype of
pik1 mutants and vice versa (Han et al., 2002).
To determine whether Lsb6 synthesizes PI4P to promote
endosome motility, we generated and analyzed several point
mutants defective in PI 4-kinase activity. Like other type II PI
4-kinases, the kinase domain of Lsb6 is interrupted by a linker
such that motifs 1, 2, 3, and 4 of the catalytic domain are lo-
cated in the NH2-terminal portion of the molecule and motifs
6 and 7 in the COOH-terminal region (Fig. 3 A and Fig. S3).
Flanking the two kinase subdomains are noncatalytic NH2-
and COOH-terminal extensions. Studies of the rat type II PI
4-kinase have identified residues required specifically for ca-
talysis; substitution of any of these residues eliminates en-
zyme activity (Barylko et al., 2002). Accordingly, we targeted
the equivalent amino acids either singly or together in NH2-
terminally HA-tagged Lsb6 to yield the following mutants:
K192M, D387A, N392A, D413A, and a quadruple mutant
(4KD) bearing all four of these substitutions (Fig. 3 A). Each
mutant form of HA-Lsb6 of the expected molecular mass was
well expressed (Fig. 3 B). We used assay conditions opti-
mized to detect the PI 4-kinase activity of Lsb6 and to mini-
mize activity of the other PI 4-kinases Stt4 and Pik1 (Han et
al., 2002). Under these conditions, we found that extracts
from cells expressing wild-type HA-Lsb6 showed robust PI
4-kinase activity relative to the low level of activity detected
in extracts from lsb6  cells expressing vector alone (Fig. 3
C). In contrast, extracts derived from cells expressing any of
the kinase domain point mutants lacked PI 4-kinase activity
above the background (Fig. 3 C).
Figure 2. Lsb6 is required for endosome motility. (A) Tracings of endo-
some paths in lsb6  cells that lack or carry a plasmid (pLSB6) expressing
wild-type Lsb6. (B) Gallery of fluorescence micrographs derived from
Video S6 and S7 that illustrate endosome position over time in lsb6  cells
lacking or carrying pLsb6. PM, plasma membrane; V, vacuole. (C) Histo-
gram showing the distribution of endosome speeds in lsb6  cells lacking
or carrying pLsb6.LSB6- AND LAS17-REGULATED ENDOSOME MOTILITY • CHANG ET AL. 137
Remarkably, expression of any of these kinase-inactive
forms of HA-Lsb6 from high copy or low copy plasmids res-
cued the endosome motility defect of lsb6  cells (Table I;
compare Video S6 [endosome motility in an lsb6  cell] to
Video S8 [endosome motility in an lsb6  cell   pHA-Lsb6
4KD]). These results indicated that the PI 4-kinase activity of
Lsb6 is dispensable for endosome motility.
PI4P generated by Stt4 or Pik1 is 
dispensable for endosome motility
Although the PI 4-kinase activity of Lsb6 is dispensable for
endosome motility, the preceding experiments could not ex-
clude a role for PI4P production by Stt4 or Pik1. Accordingly,
we examined endosome motility in a pik1 or stt4 temperature-
sensitive mutant or in an lsb6  stt4-ts double mutant. The pik1
and  stt4 temperature-sensitive mutant phenotypes were con-
firmed according to published assays that scored aberrant vacu-
olar morphology or actin patch depolarization, respectively
(Audhya et al., 2000). Inactivation of these PI 4-kinases by
temperature shift, however, did not result in defective endo-
some motility (unpublished data). These results suggested that
Pik1 and Stt4 are dispensable for endosome motility.
As a further means of exploring the role of phosphoinosi-
tide synthesis in endosome motility, we examined temperature-
sensitive mss4 mutants, which are defective in the sole PI4P
5-kinase in yeast. At nonpermissive temperature, the mss4 mu-
tant lost PI4P 5-kinase activity, as indicated by cytosolic local-
ization of a PI4,5P2 sensor (PLC-PH-GFP; Wild et al., 2004).
Under these conditions, defects in endosome motility were not
observed (unpublished data). Therefore, PI4,5P2 produced by
Mss4 is dispensable for endosome motility.
The NH2-terminal half of Lsb6 mediates 
endosome motility and Las17 interaction
Because the kinase activities of Lsb6 and other PI 4-kinases are
dispensable for endosome motility, we hypothesized that Lsb6
promotes endosome motility by interacting with Las17. To test
this hypothesis, we determined which domains of Lsb6 are neces-
sary and sufficient for endosome motility and Las17 interaction.
Accordingly, we generated a series of deletion mutants of
HA-Lsb6 expressed from plasmids in lsb6  cells (Fig. 4). All
Lsb6 deletion constructs exhibited undetectable PI 4-kinase ac-
tivity (unpublished data). Analysis of endosome motility in lsb6 
mutants expressing these constructs indicated that the NH2-termi-
nal region flanking the catalytic domain was necessary for endo-
some motility (Table I). This result is illustrated by comparing
Video S9 (endosome motility in an lsb6  cell   pHA-Lsb6 N-
terminus) and Video S7 (endosome motility in an lsb6  cell  
pLsb6). In contrast, deletion of other regions of Lsb6 did not af-
fect endosome motility (Table I). This result is illustrated by
comparing Video S10 (endosome motility in an lsb6  cell  
pHA-Lsb6 C-terminus) and Video S7 (endosome motility in an
lsb6  cell   pLsb6). Both kinds of results were confirmed quan-
titatively by using automated particle tracking and MSD plots
(Fig. S2). Expression of the NH2-terminal domain of Lsb6 res-
cued endsome motility less well than a construct containing both
the NH2-terminal domain and the first half of the kinase domain
(Table I). Taken together, these results indicated that the region
of Lsb6 containing the NH2-terminal domain and first half of the
kinase domain is necessary and sufficient for full activity.
To explore the mechanism by which Lsb6 promotes endo-
some motility, we determined whether the domains of the pro-
tein required for endosome motility also mediate interaction with
Las17. For analysis of protein–protein interactions, we used
yeast two-hybrid assays rather than coimmunoprecipitation ex-
periments because conditions that solubilized Las17 failed to
solublize Lsb6 and vice versa. The NH2-terminal domain of
Figure 3. Catalytically inactive Lsb6 point mutants. (A) Schematic of Lsb6
indicating the two halves of the kinase domain (shaded). Residues
changed singly or together to alanine to generate kinase-inactive forms of
Lsb6 are indicated. (B) Expression of HA-tagged wild-type or mutant Lsb6
in lsb6  cells detected with an anti-HA antibody. (C) PI 4-kinase activity
detected in extracts of lsb6  cells carrying wild-type or mutant Lsb6; data
shown are the average of two experiments.
Figure 4. Lsb6 deletion mutants. (A) Schematic of Lsb6 deletion mutants.
The two halves of the kinase domains are indicated in gray. The ability of
each construct to rescue endosome motility ( , no rescue,  , partial res-
cue,   , full rescue; Table I) or interact with Las17 ( , no interaction,  ,
weak interaction,   , wild-type interaction,    , stronger than wild-type
interaction; see Fig. 5) is also indicated. (B) Expression of HA-tagged Lsb6
mutant constructs in lsb6  cells. The expected sizes of wild-type and mutant
forms of HA-tagged Lsb6 in the left panel are: WT, 75 kD;  N-terminus, 50
kD;  kinase subdomain 1, 55 kD;  linker, 55 kD;  kinase subdomain 2,
52 kD; and  C-terminus, 60 kD. The expected sizes of the HA-Lsb6 con-
structs shown in the second panel are: NH2 terminus, 22 kD; kinase subdo-
main 1, 13 kD; kinase subdomain 1  linker, 25.7 kD; kinase subdomain 2,
18 kD; COOH terminus, 11.5 kD, and NH2 terminus   kinase subdomain 1,
34 kD. The asterisk indicates a degradation product.JCB • VOLUME 171 • NUMBER 1 • 2005 138
Lsb6 was required for interaction with Las17 (Fig. 5). Loss of
the NH2-terminal half of Lsb6 eliminated Las17 interaction,
whereas deletions removing the COOH-terminal region of Lsb6
preserved Las17 interaction. Furthermore, the NH2-terminal re-
gion preceding the catalytic domain of Lsb6 was sufficient to
interact strongly with Las17 (Fig. 5). Accordingly, the results
indicated that the NH2-terminal half of Lsb6 powers endosome
motility by interacting directly or indirectly with Las17.
Discussion
Here we provide new insight into mechanisms that regulate en-
docytic transport of signaling receptors. Our findings suggest
that endosomes bearing the GPCR Ste2 in yeast are transported
by actin polymerization on endosome membranes. We show
that this mechanism requires a type II PI 4-kinase and a WASp
homologue that activates the Arp2/3 complex. Whereas phos-
phoinositides have been shown previously to activate mamma-
lian N-WASp and stimulate organelle motility (Rohatgi et al.,
2000; Rozelle et al., 2000; Taunton et al., 2000; Benesch et al.,
2002), our findings show that the catalytic activity of the yeast
type II PI 4-kinase, Lsb6, is dispensable for endosome motility.
Lsb6 instead functions by interacting directly or indirectly with
the WASp homologue Las17, leading to activation of the Arp2/3
complex, actin filament assembly and endosome motility.
This is the first direct evidence indicating that a type II PI
4-kinase regulates endosome transport, and that this class of
enzyme has an important function apart from the ability to
synthesize phosphoinositides.
Actin polymerization-driven endosome 
motility
Extensive evidence has demonstrated that actin assembly in
yeast is critical for endocytic internalization and transport, and
that endosomes do not use myosin motors for transport (for re-
view see Engqvist-Goldstein and Drubin, 2003; Munn, 2000).
Endosomes that have abscised from the plasma membrane have
been proposed to move independently of actin polymerization
because Las17 and certain actin binding proteins are depleted
from endocytic F-actin patches as they internalize from the cell
cortex (Kaksonen et al., 2003). In this model, the force of inter-
nalization is hypothesized to impart momentum to endosomes,
moving them through the cytoplasm. However, whether this
mechanism could account for the distance and speed with which
endosomes travel through the viscous cytoplasm is unclear.
In contrast, results presented here and elsewhere indicate
that Ste2-containing endosomes are transported by ongoing and
continual polymerization of actin filaments from their membrane
surface. First, the actin polymerization toxins latrunculin A
and jasplakinolide rapidly ( 5 min) inihibit endosome motility
(Chang et al., 2003; unpublished results). Second, endocytic inter-
nalization is insufficient to support endosome motility because the
WCA domain of Las17 is dispensable for Ste2 internalization
whereas it is required for motility of Ste2-containing endosomes
(Chang et al., 2003). This conclusion is also supported by results
of the present study showing that endosome motility but not en-
docytic internalization is inhibited when actin filament barbed
ends are capped by overexpressing capping protein. Third, attach-
ing the WCA domain of Las17 to the endocytic cargo Ste2 rescues
the motility defect of las17 WCA cells. Fourth, Ste2-containing
endosomes can stop and start, make sharp turns or reverse direc-
tion (Chang et al., 2003), indicating that movement is not inertial.
These observations are consistent with two hypotheses.
First, Las17 activates the Arp2/3 complex on the plasma
membrane, producing endosomes with uncapped actin fila-
ments that continue to polymerize and depolymerize, thereby
powering movement. Alternatively, Las17 activates the Arp2/3
complex directly on endosome membranes, thereby stimulating
ongoing actin filament assembly that drives motility. Although
the Arp2/3 complex, Las17 and F-actin have yet to be lo-
calized on Ste2-labeled endosomes, these proteins may be
present below the detection limit because endosomes are small
and actin filaments are short.
Does yeast have more than one 
endocytic process?
To integrate our findings with those of previous investigations,
we suggest that yeast cells possess at least two endocytic pro-
cesses distinguished by their internalization sites and mecha-
nisms of endosome transport via the actin cytoskeleon, analogous
to the diverse roles of the mammalian actin cytoskeleton in en-
docytosis (reviewed in Engqvist-Goldstein and Drubin, 2003).
One process mediates endocytosis of the GPCR Ste2; whether
other cargo use this mechanism remains to be determined. In
this mechanism, Ste2 internalizes at small invaginations associ-
ated with relatively little actin, as shown by immunoelectron
microscopy (Mulholland et al., 1999). As Ste2-containing endo-
somes form, they continue to nucleate actin filaments by a
mechanism requiring Las17 and the Arp2/3 complex (Chang et
al., 2003; results of the present investigation), thereby transport-
ing endosomes along irregularly shaped paths to the lysosome-
like vacuole. Such nonlinear motility may also allow endocytic
cargo to recycle to the plasma membrane, as occurs with the
GPCR Ste3 (Davis et al., 1993; Luo and Chang, 2000).
In a second process, endocytic internalization occurs at
cortical F-actin patches, as observed using FM 4–64 or GFP-
Figure 5. The NH2 terminus of Lsb6 interacts with Las17. Interaction of
the indicated Lsb6 and Las17 constructs was assayed by performing yeast
two-hybrid experiments. Results of  -galactosidase assays are average   SD
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labeled actin-binding proteins. Here, Pan1, Las17, type I myo-
sins (Myo3 and Myo5), and other proteins activate the Arp2/3
complex (Evangelista et al., 2000; Geli et al., 2000; Lechler et
al., 2000; Duncan et al., 2001; Young et al., 2004), thereby nu-
cleating actin filament assembly and endosome scission from
the plasma membrane. A subpopulation of the endosomes pro-
duced by this mechanism are transported to the vacuole along
actin cables that treadmill (Huckaba et al., 2004). This transport
process may efficiently couple secretion and endocytosis during
polarized cell growth because cortical actin patches colocalize
with the ends of actin cables and because actin cables deliver
secretory vesicles to cortical sites of cell growth (Pruyne et al.,
1998, 2002; Evangelista et al., 2002).
Type II PI 4-kinases in endocytosis and 
vesicular trafficking
Type II PI 4-kinases are a newly appreciated family of enzymes
characterized by catalytic domains dissimilar to those of other PI
kinases (Minogue et al., 2001; Wei et al., 2002). Mammalian
cells express   and   isoforms of type II PI 4-kinase that are
products of distinct genes. Type II PI 4-kinases are peripheral
membrane proteins that associate with the plasma membrane,
ER, Golgi apparatus, endosomes, synaptic vesicles, and F-actin
(Balla et al., 2002; de Graaf et al., 2002; Guo et al., 2003; Wang
et al., 2003; Waugh et al., 2003; Carloni et al., 2004). The type
II  isoform produces a pool of PI4P that recruits protein scaf-
folds implicated in cytoskeletal organization and synaptic vesicle
budding (Guo et al., 2003), or that regulates the clathrin adaptor
AP-1 on Golgi membranes (Wang et al., 2003). Otherwise, the
functions of type II PI 4-kinases are poorly understood.
Before our study, Lsb6, the sole type II PI 4-kinase of
yeast, had been characterized biochemically (Han et al., 2002;
Shelton et al., 2003). However, its function was unknown be-
cause lsb6  mutants did not exhibit growth defects (Han et al.,
2002; Shelton et al., 2003), in contrast to the lethal growth
deficits of mutants defective in the type III PI 4-kinases Stt4 or
Pik1. However, we show herein that Lsb6 is required for the
motility of endosomes containing Ste2, a novel function for
type II PI 4-kinases. Strikingly, we find that the PI 4-kinase ac-
tivity of Lsb6 is completely dispensable for endosome motility.
Instead, Lsb6 promotes endosome motility by interacting di-
rectly or indirectly with the WASp homologue Las17, which in
turn activates the Arp2/3 complex, resulting in actin filament
assembly on endosome membranes. This conclusion is sup-
ported by results showing that the NH2-terminal half of Lsb6 is
necessary and sufficient for endosome motility and interaction
with Las17. The NH2 terminus of Lsb6 is highly conserved
among fungi, with two clusters of conserved hydrophobic resi-
dues that may play a role in this process (Fig. S4).
Several findings suggest that Lsb6 may promote endo-
some motility by activating Las17. First, Lsb6 and Las17 local-
ize to plasma and vacuole membranes (Madania et al., 1999;
Eitzen et al., 2002). Second, Las17 functions downstream of
Lsb6 because appending the WCA domain of Las17 to Ste2
rescues the endosome motility defect of lsb6  mutants. Third,
Lsb6 may activate rather than recruit Las17 because Las17 is
localized normally in lsb6  mutants (unpublished data). Bio-
chemical studies are underway to determine whether Lsb6
stimulates the ability of Las17 to activate the Arp2/3 complex.
In conclusion, our findings support the hypothesis that
endosomes bearing the GPCR Ste2 move by force generated
from ongoing polymerization of actin filaments on endosome
membranes via the action of the WASP homologue Las17 and
the Arp2/3 complex. This mechanism requires a type II PI
4-kinase, Lsb6, functioning independently of its enzymatic ac-
tivity as an upstream regulator of Las17. Because Lsb6, Las17,
and the Arp2/3 complex are highly conserved in eukaryotes,
their counterparts in other organisms may have critical roles reg-
ulating endocytic transport of many signaling receptors, trans-
porters, or intracellular pathogens.
Table II. Yeast strains used in this study
Strain Genotype Source
BY4741 MATa his3 1 leu2  met15  ura3  M. Linder
BY4741 lsb1  MATa his3 1 leu2  met15  ura3  lsb1 ::kanMXR M. Linder
BY4741 lsb2  MATa his3 1 leu2  met15  ura3  lsb2 ::kanMXR M. Linder
BY4741 lsb3  MATa his3 1 leu2  met15  ura3  lsb3 ::kanMXR M. Linder
BY4741 lsb4  MATa his3 1 leu2  met15  ura3  lsb4 ::kanMXR M. Linder
BY4741 lsb5  MATa his3 1 leu2  met15  ura3  lsb5 ::kanMXR M. Linder
BY4741 lsb6  MATa his3 1 leu2  met15  ura3  lsb6 ::kanMXR M. Linder
BY4741 lsb1 , lsb2  MATa his3 1 leu2  met15  ura3  lsb1 ::kanMXR lsb2 ::kanMXR This lab
BY4741 lsb3 , lsb4  MATa his3 1 leu2  met15  ura3  lsb3 ::kanMXR lsb4 ::kanMXR This lab
BY4741 lsb3 , lsb5  MATa his3 1 leu2  met15  ura3  lsb3 ::kanMXR lsb5 ::kanMXR This lab
pik1  MATa pik1 ::TRP1 ade2-101och his3-d200 leu2-1 lys2-801a trp1-d ura3-52 J. Thorner
pik1-83 MATa pik1-83:TRP1 ade2-101och his3- 200 leu2-1 lys2-801a trp1-d ura3-52 J. Thorner
SEY6210 MATa ura3-5 trp1-903 his3- 200 leu2-3 112, lys 2-801  S. Emr
AAY102 MATa stt4 ::HIS3 ura3-5 trp1-903 his3- 200 leu2-3 112, lys 2-801 suc2 9 [pLEU2 CEN stt4-4] S. Emr
AAY201 MATa mss4 ::HIS3MX6 ura3-5 trp1-903 his3- 200 leu2-3 112, lys 2-801 suc2 9 [pRS416 URA3 CEN MSS4] S. Emr
AAY202 MATa mss4 ::HIS3MX6 ura3-5 trp1-903 his3- 200 leu2-3 112, lys 2-801 suc2 9 [pRS416 URA3 CEN mss4-2] S. Emr
KBY58 MATa ste2::LEU2 sst1- 5 leu2-3,112 ura3-52 his3- 1 trp1 This lab
KBY66&ret; MATa ste2::leu2 sst1- 5 leu2-3,112 ura3-52 his3- 1 trp1 las17 WCA::12myc kanR This lab
PJ69-4A MATa trp1-901 leu2-3, 112 ura3-52 his3 -200 gal4  gal80  LYS2::GAL1-HIS3 GAL2-ADE2 met2::GAL7-LacZ M. Johnston
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Materials and methods
Yeast strains, plasmids, and growth conditions
Yeast strains are listed in Table II. Yeast cultures were grown at 30 C, except
for temperature-sensitive mutants that were grown at 25 C and then shifted to
nonpermissive temperature (37 C). An lsb6  strain was generated in various
genetic backgrounds by replacing the open reading frame with a kanamycin
resistance gene. Knockouts were verified by growth on G418-containing
plates; genomic PCR confirmed that the locus of interest was replaced.
Plasmids are listed in Table III. For construction of pRS316-Lsb6, the
promoter, terminator, and open reading frame of LSB6 was PCR-amplified
from genomic DNA (chromosome X from coordinates 237180 to 239003)
with NotI and BamHI restriction sites and cloned into pRS316. For construc-
tion of pRS423PGK-HA-Lsb6, the open reading frame from pRS316-Lsb6
was PCR amplified with two HA tags designed into the 5  primer with
BamHI sites. This fragment was cloned into pRS423PGK (Overton and
Blumer, 2000). For construction of kinase-dead Lsb6 point mutants, site-
directed mutagenesis was done according to the manufacturer’s instructions
(Quikchange Site Directed Kit; Strategene). For construction of Lsb6 deletion
mutants, PCR-based deletion mutagenesis was done according to the man-
ufacturer’s instruction (ExSite; Strategene). To generate two hybrid vectors,
wild-type Lsb6, kinase-dead mutants, or deletion constructs were subcloned
from the appropriate pRS423PGK constructs into pGBDU-C1 as BamHI
fragments downstream and in-frame of the DNA binding domain (James et
al., 1996). To generate the pGAD-Las17 construct, Las17 was PCR ampli-
fied from pRS313Las17 (Chang et al., 2003) with a single amino-terminal
myc tag and cloned into pGAD-C1 (James et al., 1996) as a BamHI
fragment. To generate WCA fusion proteins, the 90–amino acid COOH
terminus of Las17 was PCR amplified from genomic DNA with NheI restric-
tion sites and cloned into NheI sites in pRS313Ste2 or pRS426Hxt1 (Stefan
et al., 1998; Overton and Blumer, 2000). All constructs were verified by
DNA sequencing and by immunoblotting.
Antibodies and immunoblotting methods
Anti-HA (HA.11) and anti-myc (9E10) antibodies were purchased from Co-
vance and used according to the manufacturer’s instructions. Capping pro-
tein antibody was a gift of J. Cooper (Washington University School of
Medicine, St. Louis, MO) and used according to published directions (Am-
atruda et al., 1992). HRP-conjugated secondary antibodies were purchased
from GE Healthcare and used according to manufacturer’s instructions.
Fresh transformants were grown overnight to saturation and then harvested
and washed in cold water. Cells were lysed at 4 C with glass beads in cold
lysis buffer (10% glycerol, 0.1 M NaCl, 50 mM Tris-Cl, pH 8.0, 1 mM
EDTA, 1 mM EGTA) with fresh protease inhibitors (0.1 mg/ml PMSF, 0.1
mg/ml benzamidine, 0.75 mg/ml TAME, 1 ng/ml pepstatin A, 0.1 mg/ml
leupeptin, and 50 ng/ml aprotinin) until 90% lysis was achieved as indi-
cated by phase contrast microscopy. Lysates were spun at 5,000 g for 5
min at 4 C and clarified lysates were removed. Protein concentration was
determined by using the Bio-Rad protein assay kit (Bio-Rad Laboratories).
SDS-PAGE electrophoresis and immunoblotting was performed according to
the manufacturer’s instructions (Bio-Rad Laboratories).
PI 4-kinase assays
Cells were grown to exponential phase (OD600   0.5). We grew lsb6 
cells in synthetic complete (SC) medium and lsb6  cells containing plas-
mids in synthetic complete medium lacking histidine and uracil. Cell ex-
tracts were prepared as described previously (Han et al., 2002). For im-
munoblot analysis, cell extracts were resolved by SDS-PAGE using a 10%
slab gel, transferred to a PVDF membrane, and subjected to reaction with
anti-HA antibodies at a concentration of 1  g/ml. PI 4-kinase activity was
measured for 10 min at 30 C in the presence of 50 mM Tris-maleate (pH
7.0), 2.5 mM [ -
32P]ATP (10,000 cpm/nmol), 10 mM MgCl2, 0.2 mM PI,
3.2 mM Triton X-100, and 20  g of cell extract protein in a total volume
of 0.1 ml (these are optimal conditions for Lsb6 kinase activity relative to
other PI 4-kinases as described in Han et al. (2002). The 
32P-labeled chlo-
roform-soluble products of the reaction were dried and used for scintilla-
tion counting. All assays were conducted in triplicate and were linear with
time and protein concentration. A unit of PI 4-kinase activity was defined
as the amount of enzyme that catalyzed the formation of 1 nmol of prod-
uct/min. Specific activity was defined as units per mg of protein.
Microscopy
Rhodamine-phalloidin (Invitrogen) and FM 4–64 (Invitrogen) were used ac-
cording to the manufacturers’ directions. The plasmid pUG34-PLCPH2GFP
was used according to published methods (Wild et al., 2004). Yeast cells
were grown in synthetic dextrose media overnight, subcultured, and allowed
to grow overnight to an OD600 of 0.25–0.4. Cells were then washed twice
and concentrated in nonfluorescent media. For temperature-sensitive mu-
tants, all mutants were grown in synthetic media and switched to nonpermis-
sive temperature for the indicated times, washed twice with nonfluorescent
media, and visualized immediately on a heated microscope stage. For cap-
ping protein overexpression, cells were grown in synthetic media containing
raffinose overnight. Induction was done by adding galactose to a final con-
centration of 2%, and cells were allowed to induce to 2 h until maximal ex-
pression was achieved as indicated by immunoblotting. Cells were mounted
on glass slides, covered with a glass coverslip, and viewed with an Olym-
pus IX70 inverted epifluorescence microscope and a cooled CCD cam-
era (RC300; Dage-MTI). Single focal plane images were obtained using
U-MNG (rhodamine-phalloidin) and U-MWIBA (GFP) filter sets captured using
NIH Image (http://rsb.info.nih.gov/nih-image). Each frame was taken by in-
tegrating for 300–500 ms; frames were separated by 500–700 ms until 50
frames had been acquired. For experiments using temperature-sensitive mu-
tants, a plastic tent was set up such that the microscope system was heated
for 2–3 h before the experiment and maintained at the indicated nonpermis-
sive temperature for the duration of the experiment.
Table III. Plasmids used in this study
Plasmid Source
pRS426 Ste2-GFP  This lab
pRS426 Ste2-CFP  This lab
pRS313 Lsb6 This lab
pRS313 Ste2-WCA This lab
pRS313 Ste2-WCA-YFP This lab
pRS426 Hxt1-WCA This lab
pRS426 Hxt1-WCA-YFP This lab
pUG34 PLCPH2GFP A. Wild
pRS423 PGK HA-Lsb6 This lab
pRS423 PGK HA-Lsb6 K192M This lab
pRS423 PGK HA-Lsb6 D387A This lab
pRS423 PGK HA-Lsb6 N392A This lab
pRS423 PGK HA-Lsb6 D413A This lab
pRS313 PGK HA-Lsb6 K192M This lab
pRS423 PGK HA-Lsb6 4KD (K192M, D387A, N392A, 
K192M)
This lab
pRS423 PGK HA-Lsb6  N-terminus This lab
pRS423 PGK HA-Lsb6  kinase subdomain 1  This lab
pRS423 PGK HA-Lsb6  linker This  lab
pRS423 PGK HA-Lsb6  kinase subdomain 2  This lab
pRS423 PGK HA-Lsb6  C-terminus This lab
pRS423 PGK HA-Lsb6 N-terminus This lab
pRS423 PGK HA-Lsb6 kinase subdomain 1 This lab
pRS423 PGK HA-Lsb6 kinase subdomain 1   linker This lab
pRS423 PGK HA-Lsb6 kinase subdomain 2 This lab
pRS423 PGK HA-Lsb6 C-terminus This lab
pGAD MYC-Las17 This lab
pGBDU HA-Lsb6 This lab
pGBDU HA-Lsb6 K192M This lab
pGBDU HA-Lsb6 D387A This lab
pGBDU HA-Lsb6 N392A This lab
pGBDU HA-Lsb6 D413A This lab
pGBDU HA-Lsb6  N-terminus This lab
pGBDU HA-Lsb6  kinase subdomain 1  This lab
pGBDU HA-Lsb6  linker This  lab
pGBDU HA-Lsb6  kinase subdomain 2  This lab
pGBDU HA-Lsb6  C-terminus This lab
pGBDU HA-Lsb6 N-terminus This lab
pGBDU HA-Lsb6 kinase subdomain 1 This lab
pGBDU HA-Lsb6 kinase subdomain 1   linker This lab
pGBDU HA-Lsb6 kinase subdomain 2 This lab
pGBDU HA-Lsb6 C-terminus This lab
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Quantification of endosome motility
Time-lapse images of cells expressing Ste2-GFP were analyzed manually
and where indicated by using automated procedures. For manual analy-
sis, four sequential frames from movies were chosen and three endosomes
were tracked in the XY plane. Very bright late endosomes near the va-
coule or GFP aggregates on the plasma membrane were not scored. As
endosomes in wild-type cells are highly motile, four frames in any given
movie were sufficient to analyze motility of several endosomes. The num-
ber of endosomes per cell was variable as a function of growth conditions
(unpublished data). The distance traveled by a given endosome between
each time point was calculated based on pixel coordinates (10.2 pixels/
micron), which allowed the average speed of each endosome to be calcu-
lated. For a given cell type or experimental condition, the average endo-
some speed, standard error and P value were calculated from data ob-
tained by imaging 35–72 endosomes (Table I) using the unpaired Student’s
t test. A P value   0.005 when compared with matched wild-type controls
was considered significant. For each experiment, three independent trans-
formants were isolated, visualized, and the data quantified. Each experi-
ment was repeated two to four times.
When using an automated particle tracking program to analyze en-
dosome motility (TrackerX; Carlsson et al., 2002), we transferred time-
lapse images into text files using ImageJ 1.32g (http://rsb.info.nih.gov/
objectimage). Endosomes were tracked for a minimum of 5 s as described
previously (Carlsson et al., 2002); data obtained from 60 to 140 endo-
somes were averaged per experiment. Because  70% of endosomes in
wild-type cells moved rapidly and left the plane of focus over a period of
25 s, shorter time courses (10–15 s) were used. Conversely, poorly motile
endosomes in mutants remained in the plane of focus much longer.
Yeast two hybrid assays
Two hybrid plasmids were introduced into PJ69-4A cells as described by the
manufacturer (CLONTECH Laboratories, Inc.). At least three transformants
were isolated and assayed for  -galactosidase activity in extracts using
o-nitrophenyl-BD-galactopyranoside (ONPG; Sigma-Aldrich) as substrate.
Results shown are the average of at least three independent experiments.
Online supplemental material
Online supplemental materials are available at http://www.jcb.org/cgi/
content/full/jcb.200501086/DC1.
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